Information  X 
Enter a valid email address

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

By BFN News | 08:30 AM | Tuesday 17 March, 2020


Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8000p (from 8500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t